Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2000
10/05/2000WO2000057861A2 Use of cytidine derivatives for the treatment of leukaemia
10/05/2000WO2000057837A2 Compositions and methods for effecting the levels of cholesterol
10/05/2000WO2000057707A1 Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof
10/05/2000WO2000032228A3 Peptide-based vaccine for influenza
10/05/2000WO2000031127A3 Protein fragments for use in protein targeting
10/05/2000WO2000029574A3 Inflammation-associated genes
10/05/2000WO2000029433A3 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000027880A3 Rantes-derived peptides with anti-hiv activity
10/05/2000WO2000026379A3 Polypeptide mediating cell permeability
10/05/2000WO2000025811A3 Multicomponent meningococcal vaccine
10/05/2000WO2000025804A3 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
10/05/2000WO2000023088A3 Methods of administering adenoviral vectors
10/05/2000WO2000020638A9 Methods and compositions for the diagnosis and therapy of prostate cancer
10/05/2000WO2000011179A9 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000WO1998041232A3 Compositions for modulating responsiveness to corticosteroids
10/05/2000DE19915178A1 Hepatitis C Virus Zellkultursystem Hepatitis C virus cell culture system
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368790A1 Attenuated dengue-3 virus vaccine
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368674A1 Multivalent dengue virus vaccine
10/05/2000CA2368673A1 Attenuated dengue-4 virus vaccine
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368233A1 Recombinant neospora antigens and their uses
10/05/2000CA2368014A1 Casb619 involved in colon cancers
10/05/2000CA2367901A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000CA2367424A1 Hookworm platelet inhibitor
10/05/2000CA2366012A1 Methods of treating leukemia
10/05/2000CA2365728A1 Attenuated dengue-1 virus vaccine
10/05/2000CA2365415A1 Adaptation of virus to vertebrate cells
10/05/2000CA2365411A1 Attenuated dengue-2 virus vaccine
10/05/2000CA2363716A1 49 human secreted proteins
10/05/2000CA2329261A1 Susceptibility to psoriasis
10/05/2000CA2329152A1 Peptide vaccine for canine allergy
10/04/2000EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease
10/04/2000EP1040187A2 Human protein kinase and kinase inhibitors
10/04/2000EP1040124A1 Novel abc transporter
10/04/2000EP1040123A2 Human papillomavirus vaccine
10/04/2000EP1039933A2 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS
10/04/2000EP1039931A1 Multivalent recombinant antibodies for treating hrv infections
10/04/2000EP1039930A2 Adjuvanted vaccine formulation
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP1039928A1 Intranasal yellow fever vaccination
10/04/2000EP1039927A1 UGC (UPSTREAM GENE OF cdsA)
10/04/2000EP1039926A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity
10/04/2000EP1039889A1 Immunoglobulin-rich milk, production and use thereof
10/04/2000EP0821583B1 Dna vaccines against rotavirus infections
10/04/2000EP0705109B1 Adjuvants for vaccines against respiratory syncytial virus
10/04/2000EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof
10/04/2000CN1268573A Carrier for expressing Chiense chicken pox virus vaccine strain
10/04/2000CN1268377A Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action
10/04/2000CN1057128C Sensory nerve antibody and prepn. method therefor
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/03/2000US6127527 Apparatus for the therapeutic use of 213 Bi
10/03/2000US6127522 CRFG-1a, a target and marker for chronic renal failure
10/03/2000US6127345 Utilizing glucose 6-phosphate dehydrogenase gene polypeptide for the protection against infection, particularly bacterial infections
10/03/2000US6127164 Diagnosis using dna which specifically hybridizes under high stringency conditions to genomic dna of type 57
10/03/2000US6127163 Viral vector which codes exogenous proteins; for use as therapeutic tools in drug delivery
10/03/2000US6127159 Enzymatic polypeptide; for diagnosis and treatment of amyotrophic lateral sclerosis, huntington's disease, parkinson's disease, and alzheimer's disease; for gene therapy
10/03/2000US6127151 Antigenic preparations and the isolation of such preparations
10/03/2000US6127147 Sensor histidine kinase of Staphylococcus Aureus
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6127113 Testing mammals for microorganismal induced dietetics; obtaining sample, testing for the presence of nucleotide sequences, screening for presence microorganismal nucleotide sequences
10/03/2000US6127112 Avian herpesvirus-A antigen precursor gene
10/03/2000US6126945 Tumor killing effects of enterotoxins, superantigens, and related compounds
10/03/2000US6126938 Administering two identical or different products each containing inducing agent for the immune response, selected from the antigen and, if the antigen is protein in nature, an expression cassette capable of expressing the antigen
10/03/2000US6126937 Clpl polypeptides, polynucleotides encoding clpl polypeptides and methods for producing such polypeptides by recombinant techniques.
09/2000
09/30/2000CA2267481A1 Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection
09/28/2000WO2000057185A1 Method for detecting superantigen activity in a biological sample
09/28/2000WO2000056915A1 Ispa from streptococcus pneumoniae
09/28/2000WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
09/28/2000WO2000056884A1 pksG
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056873A1 mvaA
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056774A1 Methods of using bioelastomers
09/28/2000WO2000056773A1 Antibodies specific for cyp1b1
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056405A2 Human tumor necrosis factor receptor-like 2
09/28/2000WO2000056365A1 Use of trehalose for stabilising a liquid vaccine
09/28/2000WO2000056363A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
09/28/2000WO2000056362A2 Polycationic carbohydrates as immunostimulants in vaccines
09/28/2000WO2000056361A2 Vaccine composition
09/28/2000WO2000056360A2 Vaccine against antigens from bacteriae
09/28/2000WO2000056359A2 Vaccine against streptococcus pneumoniae